Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients.

Tue Wenzel KragstrupHelene Søgaard SinghIda GrundbergAne Langkilde-Lauesen NielsenFelice RivelleseArnav MehtaMarcia B GoldbergMichael R FilbinPer QvistBo Martin Bibby

Published in: PloS one (2021)

This study suggests that measuring plasma ACE2 is potentially valuable in predicting COVID-19 outcomes. Further, ACE2 could be a link between COVID-19 illness severity and its established risk factors hypertension, pre-existing heart disease and pre-existing kidney disease.

Keyphrases

coronavirus disease
sars cov
angiotensin converting enzyme
risk factors
angiotensin ii
respiratory syndrome coronavirus
pulmonary hypertension
type diabetes
metabolic syndrome